Prescription THC Shows Promise for PTSD-Related Nightmares
A prescription tetrahydrocannabinol (THC) medication has demonstrated encouraging results in reducing one of PTSD's most persistent symptoms: recurring nightmares tied to traumatic memories.
The study found that more than one-third of participants reported their nightmares disappeared completely after ten weeks of treatment with the THC formulation. This outcome represents a potential breakthrough for patients who have struggled with sleep disturbances that are notoriously difficult to treat with existing therapies.
Nightmare symptoms are among the most distressing aspects of PTSD, often perpetuating the cycle of trauma by disrupting sleep quality and reinforcing emotional dysregulation. Current treatment options for this specific symptom remain limited, leaving many patients without adequate relief.
Researchers noted that the results could point toward a long-awaited alternative for managing this challenging aspect of post-traumatic stress disorder. The study adds to a growing body of evidence exploring how cannabinoid-based treatments may address symptoms that conventional medications have failed to adequately control.